Abstract:Neural induction, both in vivo and in vitro, includes cellular and molecular changes that result in phenotypic specialization related to specific transcriptional patterns. These changes are achieved through the implementation of complex gene regulatory networks. Furthermore, these regulatory networks are influenced by epigenetic mechanisms that drive cell heterogeneity and cell-type specificity, in a controlled and complex manner. Epigenetic marks, such as DNA methylation and histone residue modifications, are highly dynamic and stage-specific during neurogenesis. Genome-wide assessment of these modifications has allowed the identification of distinct non-coding regulatory regions involved in neural cell differentiation, maturation, and plasticity. Enhancers are short DNA regulatory regions that bind transcription factors (TFs) and interact with gene promoters to increase transcriptional activity. They are of special interest in neuroscience because they are enriched in neurons and underlie the cell-type-specificity and dynamic gene expression profiles. Classification of the full epigenomic landscape of neural subtypes is important to better understand gene regulation in brain health and during diseases. Advances in novel next-generation high-throughput sequencing technologies, genome editing, Genome-wide association studies (GWAS), stem cell differentiation, and brain organoids are allowing researchers to study brain development and neurodegenerative diseases with an unprecedented resolution. Herein, we describe important epigenetic mechanisms related to neurogenesis in mammals. We focus on the potential roles of neural enhancers in neurogenesis, cell-fate commitment, and neuronal plasticity. We review recent findings on epigenetic regulatory mechanisms involved in neurogenesis and discuss how sequence variations within enhancers may be associated with genetic risk for neurological and psychiatric disorders.

Neuronal enhancers fine-tune adaptive circuit plasticity

Chronic Neuronal Inactivity Utilizes the mTOR-TFEB Pathway to Drive Transcription-Dependent Autophagy for Homeostatic Up-Scaling

Enhancers Active in Dopamine Neurons Are a Primary Link Between Genetic Variation and Neuropsychiatric Disease.

Genome-wide identification and characterization of functional neuronal activity-dependent enhancers

A Unified Computational Model of the Genetic Regulatory Networks Underlying Synaptic, Intrinsic and Homeostatic Plasticity

Epigenetic Basis of Neuronal and Synaptic Plasticity

Epigenetics of neural differentiation: Spotlight on enhancers

A Novel Conditional Genetic System Reveals That Increasing Neuronal Camp Enhances Memory and Retrieval

Network Analysis of Enhancer-Promoter Interactions Highlights Cell-Type-Specific Mechanisms of Transcriptional Regulation Variation

Controlling the Expression Level of the Neuronal Reprogramming Factors for a Successful Reprogramming Outcome

Progress in Neural Plasticity

Elevated EGR1 Binding at Enhancers in Excitatory Neurons Correlates with Neuronal Subtype-Specific Epigenetic Regulation

Epigenetics and the timing of neuronal differentiation

De novo human brain enhancers created by single-nucleotide mutations

An expansion of the non-coding genome and its regulatory potential underlies vertebrate neuronal diversity

Comprehensive network modeling approaches unravel dynamic enhancer-promoter interactions across neural differentiation

Activation, Decommissioning, and Dememorization: Enhancers in a Life Cycle.

Combinatorial Transcription Factor Binding Encodes Cis-Regulatory Wiring of Forebrain GABAergic Neurogenesis

Excitation–transcription coupling, neuronal gene expression and synaptic plasticity

New light on cortical neuropeptides and synaptic network plasticity

CRISPR Activation Screens Systematically Identify Factors that Drive Neuronal Fate and Reprogramming